>

Exosome Protocol Robot

AI-Powered Regenerative Medicine Protocol Generator

Evidence-BasedFDA Compliant
Regulatory Status: Mesenchymal exosome products are currently unapproved for commercial clinical use. This tool synthesizes published protocols for research and educational purposes only. Clinical use requires FDA IND approval.
Nano banana pro exosome delivery routes visualization

20 Billion Mesenchymal Exosome Protocol Suite

Generate evidence-based regenerative medicine protocols across IV, nebulized, and direct injection delivery routes. Powered by 200+ intensive clinical studies.

Intravenous

Systemic distribution via IV infusion. Superior efficacy for systemic conditions.

Phase II Clinical Trials

Nebulized

Pulmonary delivery via nebulization. Enhanced local bioavailability.

Phase I/II Trials

Direct Injection

Localized delivery via injection. Targeted tissue repair.

Phase I Trials

Select a delivery route to begin protocol generation

Intensive Protocol Badge

Intensive Protocol Mode

Enable advanced dosing protocols and extended treatment schedules for intensive clinical applications. Supported by 200+ clinical studies.